Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT01918761 · TERMINATED
Trial details
- NCT number
- NCT01918761
- Sponsor
- Central European Cooperative Oncology Group
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-30
- Primary completion
- 2016-09-15
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.